Gene · 4595
Papers3,741
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
581 to 600 of 3,741
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Validity of pathological diagnosis for early colorectal cancer in genetic background. | Cancer Med | 2023 | 36734304 | PubTator, text mining | PubMed |
| First-line crizotinib therapy is effective for a novel SEC31A-anaplastic lymphoma kinase fusion in a patient with stage IV lung adenocarcinoma: a case report and literature reviews. | Anticancer Drugs | 2023 | 36730620 | PubTator, text mining | PubMed |
| Understanding cancer predisposition in Singapore: What's next. | Singapore Med J | 2023 | 36722515 | PubTator, text mining | PubMed |
| Evaluation of inherited germline mutations in cancer susceptibility genes among pancreatic cancer patients: a single-center study. | Mol Med | 2023 | 36717774 | PubTator, text mining | PubMed |
| Germline heterozygous exons 8-11 pathogenic BARD1 gene deletion reported for the first time in a family with suspicion of a hereditary colorectal cancer syndrome: more than an incidental finding? | Hered Cancer Clin Pract | 2023 | 36709314 | PubTator, text mining | PubMed |
| The complementary roles of genome-wide approaches in identifying genes linked to an inherited risk of colorectal cancer. | Hered Cancer Clin Pract | 2023 | 36707860 | PubTator, text mining | PubMed |
| Clear cell stromal tumor of the lung with multinucleated giant cells: a report of a case with YAP1-TFE3 fusion. | Diagn Pathol | 2023 | 36707859 | PubTator, text mining | PubMed |
| Blocking Genomic Instability Prevents Acquired Resistance to MAPK Inhibitor Therapy in Melanoma. | Cancer Discov | 2023 | 36700848 | PubTator, text mining | PubMed |
| GWAS and functional studies suggest a role for altered DNA repair in the evolution of drug resistance in Mycobacterium tuberculosis. | Elife | 2023 | 36695572 | PubTator, text mining | PubMed |
| Pathogenic Variants in Adult-Onset Cancer Predisposition Genes in Pediatric Cancer: Prevalence and Impact on Tumor Molecular Features and Clinical Management. | Clin Cancer Res | 2023 | 36693186 | PubTator, text mining | PubMed |
| Local recurrence after successful endoscopic submucosal dissection for rectal mucinous mucosal adenocarcinoma: A case report. | World J Gastrointest Oncol | 2023 | 36684048 | PubTator, text mining | PubMed |
| Morphological and Molecular Functional Evidence of the Pharyngeal Sac in the Digestive Tract of Silver Pomfret, Pampus argenteus. | Int J Mol Sci | 2023 | 36675173 | PubTator, text mining | PubMed |
| Oncotherapeutic Strategies in Early Onset Colorectal Cancer. | Cancers (Basel) | 2023 | 36672501 | PubTator, text mining | PubMed |
| DNA Damage Response Alterations in Ovarian Cancer: From Molecular Mechanisms to Therapeutic Opportunities. | Cancers (Basel) | 2023 | 36672401 | PubTator, text mining | PubMed |
| Actionable genomic landscapes from a real-world cohort of urothelial carcinoma patients. | Urol Oncol | 2023 | 36653279 | PubTator, text mining | PubMed |
| PMS2 Pathogenic Variant in Lynch Syndrome-Associated Colorectal Cancer with Polyps. | Glob Med Genet | 2023 | 36644715 | PubTator, text mining | PubMed |
| Secondary findings in a large Pakistani cohort tested with whole genome sequencing. | Life Sci Alliance | 2023 | 36635046 | PubTator, text mining | PubMed |
| Genomic Characteristics and the Potential Clinical Implications in Oligometastatic Non-Small Cell Lung Cancer. | Cancer Res Treat | 2023 | 36634615 | PubTator, text mining | PubMed |
| Cancer Risk Associated With PTEN Pathogenic Variants Identified Using Multigene Hereditary Cancer Panel Testing. | JCO Precis Oncol | 2023 | 36634299 | PubTator, text mining | PubMed |
| Structural snapshots of base excision by the cancer-associated variant MutY N146S reveal a retaining mechanism. | Nucleic Acids Res | 2023 | 36631987 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4595/papers?page=30